"I was so disappointed when I learned Utah could soon move to ban kratom in all its forms. This decision would punish people ...

To make informed investment decisions, it’s best to understand how CFD trading compares to more traditional, long-term ...

The government shutdown has brought attention to food insecurity in the United States, as it disrupted the Supplemental ...

After a record-setting 43 days, the US government shutdown is set to end after the House passed the funding bill to reopen ...

Groww Share Price LIVE Updates: Shares of Groww opened at ₹114 per share on the BSE, marking a 14 per cent gain over the ...

Palantir Technologies Inc. is beating estimates while customer, sales and margins have room to grow further. Click here to ...

Groww's shares debuted at a 14% premium, igniting investor interest. Experts suggest cautious optimism, highlighting strong ...

Groww IPO, worth ₹6,632 crore, listed on the bourses today, November 12 with a premium of 12% on the NSE. Groww IPO allotment ...

Overview: Bitwise CIO Matt Hougan and other experts believe XRP could reach $1 billion in ETF inflows within months, led by ...

Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer”), a world-leading technology company for Bitcoin mining and AI cloud, today a ...

Coming back to SoftBank, does the $5.83 billion Nvidia exit symbolise a red flag for AI? Hardly. It’s part of a broader ...

MDNA113, Medicenna’s first-in-class tumor-anchored and masked anti-PD-1 x IL-2 bispecific program, is being evaluated in non-human primate studies, with plans for a first-in-human clinical trial to ...